It was also reported that FBP1 inhibited ERK activation and bypassed gemcitabine resistance in pancreatic cancer by blocking the interaction between IQ motif-containing GTPase activating protein 1 (IQGAP1) and MAPK [14]. The gene discussed is IQGAP1; the disease is pancreatic neoplasm.